Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background & Aims</h3><p>Nonalcoholic fatty liver disease (NAFLD), characterized by aberrant triglycerides accumulation in liver, affects the metabolism remodeling of hepatic and non‐hepatic tissues by secreting altered hepatokines. SUMO‐specific protease 2 (SENP2) is responsible for de‐SUMOylation of target protein, with broad effects on cell growth, signal transduction and developmental process. However, role of SENP2 in hepatic metabolism remains unclear.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach & Results</h3><p>Herein, we found that SENP2 was the most dramatically increased SENPs in the fatty liver, and its level was modulated by fed/fasted conditions. To define the role of hepatic SENP2 in metabolic regulation, we generated liver‐specific SENP2 knockout (Senp2‐LKO) mice. Senp2‐LKO mice exhibited resistance to HFD‐induced hepatic steatosis and obesity. RNA‐seq analysis showed that Senp2 deficiency upregulated genes involved in fatty acid oxidation and downregulated genes in lipogenesis in the liver. Additionally, ablation of hepatic SENP2 activated thermogenesis of adipose tissues. Improved energy homeostasis of both the liver and adipose tissues by SENP2 disruption prompted us to detect the hepatokines, with FGF21 identified as a key factor markedly elevated in Senp2‐LKO mice that maintained metabolic homeostasis. Loss of FGF21 obviously reversed the positive effects of SENP2 deficiency on metabolism. Mechanistically, by screening transcriptional factors of FGF21, PPARα was defined as the mediator for SENP2 and FGF21. SENP2 interacted with PPARα and deSUMOylated it, thereby promoting ubiquitylation and subsequent degradation of PPARα, which in turn inhibited FGF21 expression and fatty acid oxidation. Consistently, SENP2 overexpression in liver facilitated development of metabolic disorders.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our finding demonstrated key role of hepatic SENP2 in governing metabolic balance by regulating liver‐adipose tissue crosstalk, linking the SUMOylation process to metabolic regulation.</p></section>

Senp7 deficiency impairs lipid droplets maturation in white adipose tissues via Plin4 deSUMOylation

Senp2 Regulates Adipose Lipid Storage by De-SUMOylation of Setdb1.

Myeloid SENP3 deficiency protects mice from diet and age-induced obesity via regulation of YAP1 SUMOylation

Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

Defective Differentiation of Adipose Precursor Cells from Lipodystrophic Mice Lacking Perilipin 1

Perilipin1 Promotes Unilocular Lipid Droplet Formation Through the Activation of Fsp27 in Adipocytes

Tip60-mediated Lipin 1 Acetylation and ER Translocation Determine Triacylglycerol Synthesis Rate

Small Ubiquitin-Like Modifier (sumo) Protein-Specific Protease 1 De-Sumoylates Sharp-1 Protein and Controls Adipocyte Differentiation

SEC24A Deficiency Lowers Plasma Cholesterol Through Reduced PCSK9 Secretion

Role of SUMO-Specific Protease 2 in Leptin-Induced Fatty Acid Metabolism in White Adipocytes

SENP1 deficiency promotes ER stress-induced apoptosis by increasing XBP1 SUMOylation.

233-LB: Role of SUMO-Specific Protease 2 (SENP2) in Modulating Brown Adipose Tissue Activity

USP7 Mediates Pathological Hepatic De Novo Lipogenesis Through Promoting Stabilization and Transcription of ZNF638

Molecular Characterization of Seipin and Its Mutants: Implications for Seipin in Triacylglycerol Synthesis.

SENP1 prevents high fat diet-induced non-alcoholic fatty liver diseases by regulating mitochondrial dynamics

The Patatin‐Like Phospholipase Domain Containing Protein 7 Facilitates VLDL Secretion by Modulating ApoE Stability

Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance

Mechanistic insights into the role of USP14 in adipose tissue macrophage recruitment and insulin resistance in obesity

SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease

Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function

Let-7a-5p Regulates Animal Lipid Accumulation by Targeting Srebf2 and Thbs1 Signaling